Future Opportunities
-
Rating: +1 What are your mid- and long-term growth strategies?
The Sysmex Group has formulated its long-term management vision, labeled "A Unique & Global Healthcare Testing Company." Under this vision, we aim to be a leading company in those market segments where we can tap into our strength in healthcare testing, establishing ourselves as a unique global entity and providing customers with solutions that incorporate our advanced technology and special strengths.
Through the ongoing mid-term plan announced in May 2007, we aim to accelerate the pace of Group reforms, generate new value, and achieve sustainable growth, targeting net sales of ¥140.0 billion, ordinary income of ¥20.5 billion and ROE of 13.6% for the fiscal year ending March 31, 2010.
Positioning
. No. 1 solutions provider in the diagnostics field
. Innovative company in the life science field
. Leading company in Asia in the diagnostics field
Financial Target
. More than ¥200 bill in Net sales
. We will draw upon our collective strength to propel ourselves to a new stage.
-
Rating: +1
What is POCT? It is rumoured to be a field with high growth potential.
POCT stands for Point-Of-Care Testing, which can be carried out in operating rooms, in intensive care units, or at the patient's bedside, rather than in central laboratories that routinely examine large numbers of blood and urine samples, in order to enable faster diagnosis.
We will expand our lineup in this strategically important business by developing our own products, such as rapid influenza diagnostic kits, and licensing in POCT products through business alliances.
We will also offer software that allows customers to manage POCT products on a network by centralizing and sharing information, thereby offering comprehensive support for customer-specific testing environments.
-
Rating: +1
How do you utilize IT in the healthcare field?
Medical laboratories require advanced, diverse, low-cost testing systems. We offer total solutions for these needs, providing a link between instruments, reagents, and IT. Examples include the management via a network of test data reported through a variety of instruments, and the development of software that permits compatibility and efficient use of a wide array of data.
We are also striving to create optimal testing environments for the entire Group by setting up software development subsidiaries in the US, Belgium, China, New Zealand and Slovakia, and by integrating their know-how with IT product development bases in Japan.
In 2005, CNA Co., Ltd., who develops and sells laboratory information systems for medical institutions, was made into a Sysmex subsidiary.
* - Add your email address, if you wish to be notified when your question has been answered
